John C. Bolger

This profile gathers the share dealings of John C. Bolger in Fulgent Genetics, Inc., where the filings describe the role as board member. Between 20 May 2021 and 1 August 2022, the trades on record add up to 8 filings.

On the market, this insider has only sold: 1 sale, €7,641 in total. Outside the open market, there are 3 share grants and 4 option exercises.

The latest filing, published on 3 August 2022, reports a share grant in Fulgent Genetics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.